4th Quarter - Report

KNIGHT CAPITOL CONSULTANTS for INDIVIOR, INC.

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Alcohol and Drug Abuse ALC

Mainstreaming Addiction Treatment Act ( HR 1384; S 445, PL 117-328, Consolidated Appropriations Act)); Medication Access and Training Expansion Act, (HR 2067, HR 7667, PL 117-328); Reducing Barriers to Substance use Training Act (no bill number in this Congress).

LobbyistCovered position, as disclosed
PATRICIA KNIGHT Chief of Staff, Senator Orrin G. Hatch

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1384 (117th), H.R. 7667 (117th), H.R. 2067 (117th)

Budget/Appropriations BUD

Funding for mental health and substance abuse research and grants; issues related to regulation and pricing of pharmaceuticals in any FY 2023 Labor-HHS appropriations act or in the Consolidated Appropriations Act PL 117-328).

LobbyistCovered position, as disclosed
PATRICIA KNIGHT Chief of Staff, Senator Orrin G. Hatch

Contacted: HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

The Medicaid Re-entry Act (H.R. 955/S. 445); policies related to reimbursement of substance use disorder treatment (Restoring Hope for Mental Health and Well-Being Act, HR 7666). Possible changes in reimbursement for pharmaceuticals (HR 3, HR 5376 - Build Back Better Act, and any successor legislation, budget reconciliation legislation (no bill numbers)

LobbyistCovered position, as disclosed
PATRICIA KNIGHT Chief of Staff, Senator Orrin G. Hatch (1999-2007)

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 445 (117th), H.R. 955 (117th), H.R. 7666 (117th), H.R. 3 (117th), H.R. 5376 (117th)

Health Issues HCR

Mainstreaming Addiction Treatment Act (HR 2067, HR 7667); Drug Enforcement Administration regulation of buprenorphine under the Controlled Substances Act. Food and Drug Administration Safety and Landmark Advancement act FDASLA / FDA user fee reauthorization (HR 7667, S 4348, PL 117-70, Further Extending Government Funding Act) ; Restoring Hope for Mental Health and Well-Being Act (HR 7666); Medication Access and Training Expansion Act (HR 2067, S 2235; the Consolidated Appropriations Act PL 117-328).

LobbyistCovered position, as disclosed
PATRICIA KNIGHT Chief of Staff, Senator Orrin G. Hatch

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 7666 (117th), H.R. 2067 (117th), H.R. 7667 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.